Back
EACVI Premium Access

Ranolazine post-treatment reduces cardiotoxic effects due to Trastuzumab Emtansine: in vitro and in vivo study

Session: Poster session 2 - Cardiomyopathies
Topic: Other myocardial diseases
Speaker: Doctor N. Maurea (Naples, IT)
Event: EuroEcho-Imaging 2017

Congress Presentation

Add to my library

Like

About the speaker

Doctor Nicola Maurea

National Cancer Institute G.Pascale Foundation IRCCS, Naples (Italy)
2 presentations
2 followers

9 more presentations in this session

Significance of cardiac magnetic resonance imaging after aborted sudden cardiac death in patients with normal coronary angiography

Speaker: Doctor H. Vago (Budapest, HU)

Access
Abstract
Like
Thumbnail

Cardiac MRI for a better identification of structural heart disease in patients with ventricular arrhythmia

Speaker: Doctor E. Conte (Milan, IT)

Access
Abstract
Slides
Like
Thumbnail

Relaxin as a novel biomarker of cardiac fibrosis and left ventricular diastolic parameters in end-stage heart failure

Speaker: Doctor E. Gara (Budapest, HU)

Access
Abstract
Like
Thumbnail

Three-dimensional strain echocardiography, vascular ultrasound and cardiac biomarkers in early detection of cardiotoxicity in non-Hodgkin lymphoma patients

Speaker: Doctor D. Mihalcea (Bucharest, RO)

Access
Abstract
Like
Thumbnail

Echocardiographic guided screening for Fabry disease in a metropolitan area not already explored

Speaker: Professor R. Citro (Campobasso, IT)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster session 2 - Cardiomyopathies

Speakers: Doctor N. Maurea, Doctor H. Vago, Doctor E. Conte, Doctor E. Gara, Doctor D. Mihalcea...
Access
Like
Thumbnail

About the event

Image

EuroEcho-Imaging 2017

6 December - 9 December 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources